Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Major Histocompatibility Complex Class I-Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease.
Karrar A, Rajput B, Hariharan S, Abdelatif D, Houry M, Moosvi A, Ali I, Tan D, Noor S, Esmaeili D, Felix S, Alaparthi L, Otgonsuren M, Lam B, Goodman ZD, Younossi ZM. Karrar A, et al. Among authors: alaparthi l. Hepatol Commun. 2020 Sep 30;5(1):63-73. doi: 10.1002/hep4.1610. eCollection 2021 Jan. Hepatol Commun. 2020. PMID: 33437901 Free PMC article.
Gastroenterologists and Patients Report High Satisfaction Rates With Telehealth Services During the Novel Coronavirus 2019 Pandemic.
Dobrusin A, Hawa F, Gladshteyn M, Corsello P, Harlen K, Walsh CX, Alaparthi L, Weinstein M, Baig N, Sousa A, Gunaratnam NT. Dobrusin A, et al. Among authors: alaparthi l. Clin Gastroenterol Hepatol. 2020 Oct;18(11):2393-2397.e2. doi: 10.1016/j.cgh.2020.07.014. Epub 2020 Jul 11. Clin Gastroenterol Hepatol. 2020. PMID: 32663521 Free PMC article. Review. No abstract available.
An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease.
Younossi ZM, Karrar A, Pierobon M, Birerdinc A, Stepanova M, Abdelatif D, Younoszai Z, Jeffers T, Felix S, Jeiran K, Hodge A, Zhou W, Monge F, Alaparthi L, Chandhoke V, Goodman ZD, Petricoin EF. Younossi ZM, et al. Among authors: alaparthi l. BMC Med. 2018 Sep 12;16(1):170. doi: 10.1186/s12916-018-1136-1. BMC Med. 2018. PMID: 30205811 Free PMC article.
Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.
Pierceall WE, Sprott KM, Heikkinen T, Heikkila P, Alaparthi L, Aittomaki K, Al-Adhami M, Villegas-Bergazzi V, Meyer JL, Kutok JL, Bartkova J, Bartek J, Nevanlinna H, Weaver DT, Blomqvist C. Pierceall WE, et al. Among authors: alaparthi l. Hum Pathol. 2012 Sep;43(9):1363-75. doi: 10.1016/j.humpath.2011.08.018. Epub 2011 Dec 26. Hum Pathol. 2012. PMID: 22204715